Challenge of the Unknown: How Can We Improve Clinical Outcomes in Cancer of Unknown Primary?

Affiliations

¹ Alicia-Marie Conway, MD, The Christie NHS Foundation Trust, Manchester, United Kingdom, The University of Manchester, Manchester, United Kingdom, and Cancer Research UK Manchester Institute, Manchester, United Kingdom; Claire Mitchell, MD, PhD, The Christie NHS Foundation Trust, Manchester, United Kingdom; and Natalie Cook, MD, PhD, The Christie NHS Foundation Trust and The University of Manchester, Manchester, United Kingdom.

Comment

Alicia-Marie Conway et al. J Clin Oncol. 2019.

. 2019 Aug 10;37(23):2089-2090.

doi: 10.1200/JCO.19.00449. Epub 2019 Jun 18.

¹ Alicia-Marie Conway, MD, The Christie NHS Foundation Trust, Manchester, United Kingdom, The University of Manchester, Manchester, United Kingdom, and Cancer Research UK Manchester Institute, Manchester, United Kingdom; Claire Mitchell, MD, PhD, The Christie NHS Foundation Trust, Manchester, United Kingdom; and Natalie Cook, MD, PhD, The Christie NHS Foundation Trust and The University of Manchester, Manchester, United Kingdom.

No abstract available

Comment in

Reply to A.-M. Conway et al.
Hayashi H, Nishio K, Nakagawa K. Hayashi H, et al. J Clin Oncol. 2019 Aug 10;37(23):2090. doi: 10.1200/JCO.19.00767. Epub 2019 Jun 18. J Clin Oncol. 2019. PMID: 31211602 No abstract available.

Randomized Phase II Trial Comparing Site-Specific Treatment Based on Gene Expression Profiling With Carboplatin and Paclitaxel for Patients With Cancer of Unknown Primary Site.
Hayashi H, Kurata T, Takiguchi Y, Arai M, Takeda K, Akiyoshi K, Matsumoto K, Onoe T, Mukai H, Matsubara N, Minami H, Toyoda M, Onozawa Y, Ono A, Fujita Y, Sakai K, Koh Y, Takeuchi A, Ohashi Y, Nishio K, Nakagawa K. Hayashi H, et al. J Clin Oncol. 2019 Mar 1;37(7):570-579. doi: 10.1200/JCO.18.00771. Epub 2019 Jan 17. J Clin Oncol. 2019. PMID: 30653423 Clinical Trial.